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The Lancet Global Health 
Commission on High 
Quality Health 
Systems—where’s the 
complexity? 
The Lancet Global Health Commission 
on High Quality Health Systems in the 
Sustainable Development Goals (SDG) 
Era (HQSS Commission).1 The launch 
draws attention to the fact that high 
quality health care, rather than just 
access to health care, will be necessary 
to meet the health-related SDGs. The 
Commission aims to address the lack 
of an “agreed upon single definition” 
of high quality health systems and 
produce “science-led, multidisciplinary, 
actionable work with […] measurable 
indicators”. But phrases like single 
definition and measurable indicators 
in the context of an exercise seeking 
to strengthen quality in highly variable 
health systems in low-income and 
middle-income countries (LMICs) 
should raise red flags.
In 2012, WHO Task Force on 
Developing Health Systems Guidance 
proposed a series of processes and 
tools to support evidence-informed 
decisions about health system 
interventions.2 Many of the processes 
were adapted from clinical evidence-
based medicine and an insightful 
commentary by Peters and Bennet3 
noted that the focus on what works 
potentially overshadowed more 
pressing questions that country-level 
policy makers that needed answering, 
including: “what can work in our 
(non-research) environment?”, “how 
can we make an intervention work 
well?”, and “how can we overcome 
obstacles to implementation?”.3 To 
learn from this experience we need 
to ask how the HQSS Commission’s 
aims will assist LMIC policymakers to 
answer questions they have about 
how to improve health system quality 
or overcome known implementation 
obstacles? Two specific issues come to 
mind: how (and by default what) we 
measure and how these measures are 
subsequently used.
First, regarding how (and what) we 
measure. Empirical research (not to 
mention expert opinion) increasingly 
draws attention to the contribution 
of relational components and social 
experiences, including accountability, 
trust, and perceptions of respon-
siveness and respect, to health system 
quality.4,5 Capturing of these relational 
aspects is indispensable to the project 
of understanding health system quality 
sufficiently well as to improve it. But it 
remains unclear how such context-
specific and less tangible components 
will be incorporated into the 
Commission’s project of developing a 
universal definition and quantitative 
indicators, and how the latter will 
subsequently inform useful actions 
across highly variable settings. 
Second, the highly visible (and 
probably highly respected) nature 
of any indicators the Commission 
produces means it has an ex ante 
obligation to consider the use to 
which these metrics might be put. 
Care should be taken, for instance, 
to avoid intentional or unintentional 
promotion of a solely indicator and 
target-dependent approach to quality 
improvement. Experience from 
management sciences shows how, 
when introduced into organisations 
with traditional bureaucratic cultures 
without addressing root causes 
of the prevailing work culture (eg, 
governance structures and power 
dynamics) such targets can become 
meaningless, or worse, perverse 
incentives to game the system.6 
A focus on quality in health systems 
is obviously much needed. But the 
way in which the HQSS Commission 
defines measurement; how its efforts 
to produce quantifiable indicators take 
account of health system complexities; 
and to what use these indicators are 
subsequently put, should continue to 
be scrutinised. Without a broader effort 
to contextualise such measures, the 
current framing of the Commission’s 
aims has distinct risks. 
